Skip to main content
Clinical Trials/NCT06125015
NCT06125015CompletedNot Applicable

Unexpected ABR Results in Patients Suspected With Auditory Neuropathy Spectrum Disorder

Istanbul Medipol University Hospital0 sites11 target enrollmentStarted: January 20, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
11
Primary Endpoint
Measuring Hearing Thresholds with Electrophysiological Tests

Study Overview

Brief Summary

This study aimed to assess the clinical evaluations and potential underlying pathologies in patients diagnosed with Auditory Neuropathy Spectrum Disorder (ANSD) who exhibited unusual results in audiological tests. The research involved the retrospective analysis of audiological tests of 11 patients conducted by expert audiologists at Istanbul Medipol Mega Hospital between 2010 and 2020. These patients displayed abnormalities in their Auditory Brainstem Response (ABR) tests. The study sought to investigate patients with ANSD who presented atypical audiological findings, shedding light on the associated clinical aspects and potential causes of such anomalies.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
0 Years to 46 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Presence of wave V with cochlear microphonics

Exclusion Criteria

  • Type B tympanogram

Outcomes

Primary Outcomes

Measuring Hearing Thresholds with Electrophysiological Tests

Time Frame: 6 years

Participants' hearing thresholds and cochlear microphonics evaluated by using Auditory Brainstem Responses and Otoacoustic Emissions.

Evaluating Middle Ear Pathologies

Time Frame: 6 years

Participants' middle ear pathologies evaluated by using Tympanometry

Evaluating Hearing Thresholds by Using Behavioral Tests

Time Frame: 6 years

Participants' reactions to sounds were assessed using Free Field Audiometry or headphones. These evaluations were conducted initially at the time of diagnosis and subsequently after the patients had started using hearing aids.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Istanbul Medipol University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Berna Özge MUTLU

Audiologist

Istanbul Medipol University Hospital

Similar Trials